Schwartz Norman D's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Sep 9, 2026
- Accession no.
- 0000940805-26-000004
- Filed
- Sep 9, 2026, 6:42 PM ET
- Trade date
- Sep 4-6, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwartz Norman DCIK 0000940805 | Director, Officer (Chairman & CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2026 | Bio-Rad A Common Stock | MOption exerciseAcquired | +4,109 | $0.00 | $0 | 450,294 | Direct | |
| Sep 5, 2026 | Bio-Rad A Common Stock | FTax withholdingDisposed | −2,876 | $386.11 | −$1,110,452.36 | 447,418 | Direct | |
| Sep 6, 2026 | Bio-Rad A Common Stock | MOption exerciseAcquired | +3,455 | $0.00 | $0 | 450,873 | Direct | |
| Sep 6, 2026 | Bio-Rad A Common Stock | FTax withholdingDisposed | −1,854 | $386.11 | −$715,847.94 | 449,019 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Bio-Rad A Common Stock | AGrant or awardAcquired | +17,251 | $0.00 | $0 | 17,251 | Direct | |
| Sep 5, 2026 | Bio-Rad A Common Stock | MOption exerciseDisposed | −4,109 | $0.00 | $0 | 12,330 | Direct | |
| Sep 6, 2026 | Bio-Rad A Common Stock | MOption exerciseDisposed | −3,455 | $0.00 | $0 | 6,912 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.